Propionibacterium acnes-induced IL-8 production may be mediated by NF-κB activation in human monocytes

Journal of Dermatological Science

Volumn 29, Issue 2, 2002, Pages 97-103

  Chen, QiJie ^a   Koga, Tetsuya ^a   Uchi, Hiroshi ^a   Hara, Hiromitsu ^a   Terao, Hiroshi ^a   Moroi, Yoichi ^a   Urabe, Kazunori ^a   Furue, Masutaka ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

IL 8; NF B; P. acnes

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MACROLIDE; ROXITHROMYCIN;

ACNE; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES;

ANTI-BACTERIAL AGENTS; CELL LINE; HOMEOSTASIS; HUMANS; INTERLEUKIN-8; MONOCYTES; NF-KAPPA B; PROPIONIBACTERIUM ACNES; RNA, MESSENGER; ROXITHROMYCIN; UP-REGULATION;

EID: 0036092586     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(02)00013-0     Document Type: Article

References (33)

1. The microflora of the face and acne lesions
2. Age-related changes in the resident bacterial flora of the human face
3. Propionibacterium levels in patients with and without acne vulgaris
4. Pathogenesis of acne
5. Pilosebaceous duct obstruction and acne
6. The role of bacteria in acne vulgaris: A new approach
7. Studies of the extracellular proteolytic activity produced by Propionibacterium acnes
8. Inflammatory Diseases of the Epidermal Appendages and of Cartilage
9. Characterization of Propionibacterium acnes chemotactic factor
10. Complement activation in acne vulgaris: In vitro studies with Propionibacterium acnes and Propionibacterium graulosum
11. Analysis of the proinflammatory property of epidermal cyst contens: Chemotactic C5a anaphylatoxin generation
12. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: Implications for chronic inflammatory acne
13. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: Partial characterization and separation from interleukin-1 (IL-1)
14. Human chemokines: An update
15. In vivo, in vitro, and molecular aspects of interleukin-8 and the interleukin-8 receptors
16. Neutrophil accumulation and activation by homologous IL-8 in rabbits
17. Systemic antibiotics for treatment of acne vulgaris
18. Topically applied antibiotics in acne vulgaris
19. Immunomodulation by antibacterial agents. Is it clinically relevant
20. Anti-inflammatory activity of macrolides: A new therapeutic potential
21. Cooperative interaction of nuclear factor κB and cis-regulatory binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines
22. Molecular mechanism of interleukin-8 gene expression
23. Tumor necrosis factor α and interferon γ synergistically induce interleukin-8 production in a human gastric cancer cell line through acting concurrentlly on AP-1 and NF-κB-like binding sites of the interleukin-8 gene
24. Inceased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis, Apotential mechanism for the recruitment and activation of neutrophils in lung fibrosis
25. Histaine-induced IL-6 and IL-8 production are differentially modulated by IFN-γ and IL-4 in human keratinocytes
26. Chemokines are the main pro-inflammatory mediators in human monocytes activated by Staphylococcus aureus, peptidoglycan, and endotoxin
27. Micrococci and peptidoglycan activate TLR2 MyD88 IRAK TRAF NIK IKK NF-kB signal transduction pathway that induces transcription of interleukin-8
28. Roxithromycin inhibits cytokine production by and neutrophil attachment to human brochial epithelial cells in vitro
29. Tol-like recepter 4, but not toll-like recepter 2, is a signaling recepter for Escherichia and Salmonella lipopolysaccharides
30. Effects of long-term low-dose macrolide administration on neutrophil recruitment and IL-8 in the nasal discharge of chronic sinusitis patients
31. Antihistamic activity of a macrolide antibiotic, roxithromycin: Analysis of possible mechanisms in vitro and in vivo
32. Cellular uptake and subcellular distribution of roxithromycin and erythromycin in phagocytic cells
33. Entry of roxythromycin (RU965), imipenem, cefotaxime, trimethoprim, and metronidazole into human polymorphonuclear leukocytes